Oncology News

ESMO oncology news ensures that you're always kept up to date with the latest developments that affect you and your daily practice. Make sure you check these pages frequently, or sign up to our newsletter.

Filter

Date Title Topic
08 Oct 2014 European Medicines Agency Adopts a Final Negative Opinion for an Extension of Indications for Bevacizumab Central nervous system malignancies - Anticancer agents & Biologic therapy
07 Oct 2014 FDA Expands Approved Use of Ibrutinib for Chronic Lymphocytic Leukaemia Haematologic malignancies - Anticancer agents & Biologic therapy
06 Oct 2014 ESMO 2014: New Data on First- and Second-Line ALK Inhibition in NSCLC Patients Personalised medicine - Lung and other thoracic tumours - Anticancer agents & Biologic therapy
03 Oct 2014 European Medicines Agency Refuses a Change to the Marketing Authorisation for Vinflunine Anticancer agents & Biologic therapy
02 Oct 2014 Rare Cancers Europe Press Release: Specific Clinical Trial Methodology Needed for Rare Cancers
29 Sep 2014 European Medicines Agency Recommends Granting a Marketing Authorisation for Nintedanib Lung and other thoracic tumours - Anticancer agents & Biologic therapy
29 Sep 2014 European Medicines Agency Recommends Granting a Marketing Authorisation for Ramucirumab Gastrointestinal cancers - Anticancer agents & Biologic therapy
28 Sep 2014 ESMO 2014 Press Release: Significant Presence of Women in Oncology, but Still Under-Representation in Leadership Positions, Greek Survey Shows Bioethics, legal and economic issues
27 Sep 2014 ESMO 2014 Press Commentary: Phase III Trials Presented at ESMO 2014 Report Major Advances in Supportive Care for Cancer Patients Palliative and supportive care
27 Sep 2014 ESMO 2014 Press Release: Customising Chemotherapy in Lung Cancer: New Phase II Data Reported in Two Late-Breaking Studies Translational research - Lung and other thoracic tumours - Anticancer agents & Biologic therapy
27 Sep 2014 ESMO 2014 Press Release: Docetaxel or Pemetrexed in Addition to Cisplatin Achieve Comparable Outcomes in Non-Squamous Lung Cancer Lung and other thoracic tumours - Anticancer agents & Biologic therapy
27 Sep 2014 ESMO 2014: Rolapitant Plus Granisetron/Dexamethasone in Prevention of Chemotherapy-Induced Nausea and Vomiting Palliative and supportive care
27 Sep 2014 ESMO 2014 Press Release: Immune Checkpoint Inhibitors Provide Antitumour Activity Across Malignant Diseases Cancer Immunology and Immunotherapy
27 Sep 2014 ESMO 2014: Afatinib vs Methotrexate in Second-Line Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma Head and neck cancers - Anticancer agents & Biologic therapy
27 Sep 2014 ESMO 2014: TAS-102 Improves Overall- and Progression-Free Survival in Patients With Metastatic Colorectal Cancer Refractory to Standard Therapies Gastrointestinal cancers - Anticancer agents & Biologic therapy